To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
David HorrobinDr David Frederick Horrobin (6 October 1939 - 1 April 2003) was a medical researcher, entrepreneur, author and editor. He was a contributor to the field of essential fatty acids and an advocate of the benefits of fish oils and Evening Primrose Oil [1]. His research elucidated the physiology and biochemistry of the Omega EFA's[citation needed]. Additional recommended knowledgeBiographyDavid Horrobin was a scholar of Balliol College, Oxford, and during this time was influenced by the nutritionist Hugh Macdonald Sinclair. He taught for several years at Magdalen College, Oxford prior to his appointment as Professor and chairman of medical physiology at Nairobi University in 1969. Appointed as a reader in medical physiology at University of Newcastle upon Tyne in 1972 and in 1975 became Professor of medicine at the Université de Montréal. In 1977 he set up Efamol Ltd., an over-the-counter oil supplementation business, whose success enabled him in 1981 to set up the Efamol Research Institute in Nova Scotia. Following Horrobin's negotiation of the merger/acquisition of Efamol with the UK based company Agricultural Holdings in 1983, the business became an international concern of note[citation needed], and by 1997 was under the umbrella of the trading and intellectual property holding company listed as Scotia Pharmaceuticals with bases in Canada, Scotland and England[citation needed]. He left the Scotia in 1997, and his successor as CEO, Robert Dow, reduced the research and development pipeline of the company, regarded by Horrobin as its primary raison d'etre[citation needed]. He predicted at the time that if Dow's policies continued to be enacted, the company would be bankrupt inside three years [2]. His next business was Laxdale Ltd, which was set up to examine the use of essential fatty acids in treating Schizophrenia and neurodegenerative diseases such as Huntington's. He died before the company was well established and it too went into liquidation.[citation needed] David Horrobin founded the journals 'Medical Hypotheses' and 'Prostaglandins, Leukotrienes and Essential Fatty Acids' presently a leading journal in the phospholipid world[citation needed]. The original Editorial Board of Medical Hypotheses comprised: the double Nobel Laureate Linus Pauling, the Nobel Laureate Sir Macfarlane Burnet, the philosopher Sir Karl Popper, the Nobel Laureate in physiology Sir John Eccles and the physiologist A.C. Guyton. Among others its present board includes Antonio Damasio and the Nobel Laureate Arvid Carlsson[citation needed]. Horrobin published more than 800 papers [3], was the inventor of 114 patents, was an ISI (Institute for Scientific Information) highly cited scientist[4], and wrote or edited over twenty books. In 2002 his book, The Madness of Adam and Eve, outlining a theory of the coevolution of schizophrenia and modern humans, was runner-up in the Aventis Prize (now the Royal Society Prizes for Science Books)[5] for the best science book, behind Stephen Hawking. The ideas presented in this book formed a primary inspiration for Sebastian Faulks' novel Human Traces, published 2005, and Dr. Horrobin is acknowledged in the text. In 2001 he was diagnosed with mantle cell lymphoma of which he died in 2003. In June 2004 the scientific publisher Elsevier, having acquired Medical Hypotheses created an annual David Horrobin Prize, in his honour[6], to reward outstanding medical theory. A longtime critic of both the peer-review system[7], and certain aspects of both the grants and drug regulatory systems in western countries, his approach to medical research earned him the epithet of "maverick" in many an editorial[citation needed]. His support for Evening Primrose Oil (EPO) as a virtual panacea verged occasionally on the extreme, and led him to make claims which, with the benefit of hindsight, to some have appeared unbalanced[citation needed]. However, some modern research appears to be softening this impression[8][9]. Often cast as a thoroughgoing critic of the Medical and Scientific Establishment, and despite having hundreds of peer-reviewed papers of his own in print, Dr. Horrobin reserved his arrows most particularly for what he perceived of as the innovation-stifling influence of anonymous peer review[citation needed]. He was, in the main, however, a defender of medical science, in one example penning an critique, 'Medical Hubris'[10], of Ivan Illich's famous attack on the medical establishment, 'Medical Nemesis'. Selected Books
References
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "David_Horrobin". A list of authors is available in Wikipedia. |